
Daniel E. Kolker
Examiner (ID: 8774)
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1646, 1644, 1645 |
| Total Applications | 546 |
| Issued Applications | 177 |
| Pending Applications | 78 |
| Abandoned Applications | 291 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4880639
[patent_doc_number] => 20080154022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Transport of basic fibroblast growth factor across the blood brain barrier'
[patent_app_type] => utility
[patent_app_number] => 11/809477
[patent_app_country] => US
[patent_app_date] => 2007-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14206
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20080154022.pdf
[firstpage_image] =>[orig_patent_app_number] => 11809477
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/809477 | Transport of basic fibroblast growth factor across the blood brain barrier | May 31, 2007 | Abandoned |
Array
(
[id] => 4786809
[patent_doc_number] => 20080140138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors'
[patent_app_type] => utility
[patent_app_number] => 11/807493
[patent_app_country] => US
[patent_app_date] => 2007-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11229
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20080140138.pdf
[firstpage_image] =>[orig_patent_app_number] => 11807493
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/807493 | Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors | May 28, 2007 | Abandoned |
Array
(
[id] => 5527224
[patent_doc_number] => 20090197301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/796725
[patent_app_country] => US
[patent_app_date] => 2007-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 250
[patent_figures_cnt] => 250
[patent_no_of_words] => 264442
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11796725
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/796725 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Apr 26, 2007 | Abandoned |
Array
(
[id] => 8232642
[patent_doc_number] => 08198081
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Dopaminergic neuron progenitor cell marker 187A5'
[patent_app_type] => utility
[patent_app_number] => 12/296915
[patent_app_country] => US
[patent_app_date] => 2007-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 27856
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/198/08198081.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296915
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296915 | Dopaminergic neuron progenitor cell marker 187A5 | Apr 10, 2007 | Issued |
Array
(
[id] => 4845867
[patent_doc_number] => 20080182275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/786466
[patent_app_country] => US
[patent_app_date] => 2007-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 187460
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182275.pdf
[firstpage_image] =>[orig_patent_app_number] => 11786466
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/786466 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Apr 9, 2007 | Abandoned |
Array
(
[id] => 4802607
[patent_doc_number] => 20080014194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease'
[patent_app_type] => utility
[patent_app_number] => 11/697646
[patent_app_country] => US
[patent_app_date] => 2007-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 39304
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20080014194.pdf
[firstpage_image] =>[orig_patent_app_number] => 11697646
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/697646 | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease | Apr 5, 2007 | Abandoned |
Array
(
[id] => 4567871
[patent_doc_number] => 07829087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-09
[patent_title] => 'Methods of treating cognitive impairment'
[patent_app_type] => utility
[patent_app_number] => 11/723745
[patent_app_country] => US
[patent_app_date] => 2007-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 23892
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/829/07829087.pdf
[firstpage_image] =>[orig_patent_app_number] => 11723745
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/723745 | Methods of treating cognitive impairment | Mar 20, 2007 | Issued |
Array
(
[id] => 5159411
[patent_doc_number] => 20070172455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Chimeric Interleukin-6 Soluble Receptor/Ligand Protein, Analogs Thereof and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/688640
[patent_app_country] => US
[patent_app_date] => 2007-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13883
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172455.pdf
[firstpage_image] =>[orig_patent_app_number] => 11688640
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/688640 | Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof | Mar 19, 2007 | Issued |
Array
(
[id] => 6460042
[patent_doc_number] => 20100190210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'Protein Purification'
[patent_app_type] => utility
[patent_app_number] => 12/293732
[patent_app_country] => US
[patent_app_date] => 2007-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13960
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190210.pdf
[firstpage_image] =>[orig_patent_app_number] => 12293732
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/293732 | Protein Purification | Mar 8, 2007 | Abandoned |
Array
(
[id] => 7518910
[patent_doc_number] => 07973011
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-05
[patent_title] => 'Blockade of gamma-secretase activity to promote myelination by oligodendrocytes'
[patent_app_type] => utility
[patent_app_number] => 11/705909
[patent_app_country] => US
[patent_app_date] => 2007-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15174
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/973/07973011.pdf
[firstpage_image] =>[orig_patent_app_number] => 11705909
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/705909 | Blockade of gamma-secretase activity to promote myelination by oligodendrocytes | Feb 12, 2007 | Issued |
Array
(
[id] => 5410039
[patent_doc_number] => 20090123938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Mammalian monocyte chemoattractant protein receptors'
[patent_app_type] => utility
[patent_app_number] => 11/702711
[patent_app_country] => US
[patent_app_date] => 2007-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16472
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123938.pdf
[firstpage_image] =>[orig_patent_app_number] => 11702711
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/702711 | Methods of screening for antagonists of mammalian monocyte chemoattractant protein receptors | Feb 4, 2007 | Issued |
Array
(
[id] => 5323488
[patent_doc_number] => 20090061478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'High-Speed Quantification of Antigen Specific T-Cells in Whole Blood by Flow Cytometry'
[patent_app_type] => utility
[patent_app_number] => 12/161579
[patent_app_country] => US
[patent_app_date] => 2007-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11941
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20090061478.pdf
[firstpage_image] =>[orig_patent_app_number] => 12161579
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/161579 | High-Speed Quantification of Antigen Specific T-Cells in Whole Blood by Flow Cytometry | Jan 29, 2007 | Abandoned |
Array
(
[id] => 5119917
[patent_doc_number] => 20070141631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Methods for testing for and inhibiting the development of Huntington\'s disease'
[patent_app_type] => utility
[patent_app_number] => 11/627978
[patent_app_country] => US
[patent_app_date] => 2007-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3186
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141631.pdf
[firstpage_image] =>[orig_patent_app_number] => 11627978
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/627978 | Methods for testing for the development of Huntington's disease | Jan 27, 2007 | Issued |
Array
(
[id] => 5068881
[patent_doc_number] => 20070189982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Diagnostics and treatments of Periodontal disease'
[patent_app_type] => utility
[patent_app_number] => 11/654512
[patent_app_country] => US
[patent_app_date] => 2007-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16286
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20070189982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11654512
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/654512 | Diagnostics and treatments of Periodontal disease | Jan 17, 2007 | Abandoned |
Array
(
[id] => 5159410
[patent_doc_number] => 20070172454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'USE OF IL-6/IL-6 CHIMERA IN HUNTINGTON\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 11/622284
[patent_app_country] => US
[patent_app_date] => 2007-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11670
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172454.pdf
[firstpage_image] =>[orig_patent_app_number] => 11622284
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/622284 | USE OF IL-6/IL-6 CHIMERA IN HUNTINGTON'S DISEASE | Jan 10, 2007 | Abandoned |
Array
(
[id] => 5079658
[patent_doc_number] => 20070122882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'GENE SPECIFICALLY EXPRESSED IN POSTMITOTIC DOPAMINERGIC NEURON PRECURSOR CELLS'
[patent_app_type] => utility
[patent_app_number] => 11/622312
[patent_app_country] => US
[patent_app_date] => 2007-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17931
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20070122882.pdf
[firstpage_image] =>[orig_patent_app_number] => 11622312
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/622312 | GENE SPECIFICALLY EXPRESSED IN POSTMITOTIC DOPAMINERGIC NEURON PRECURSOR CELLS | Jan 10, 2007 | Abandoned |
Array
(
[id] => 5177493
[patent_doc_number] => 20070178553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Mammalian T-type calcium channels'
[patent_app_type] => utility
[patent_app_number] => 11/649452
[patent_app_country] => US
[patent_app_date] => 2007-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8833
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20070178553.pdf
[firstpage_image] =>[orig_patent_app_number] => 11649452
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/649452 | Nucleic acids encoding mammalian T-type calcium channels | Jan 2, 2007 | Issued |
Array
(
[id] => 341505
[patent_doc_number] => 07501263
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-10
[patent_title] => 'Nucleic acids encoding mammalian T-type calcium channels'
[patent_app_type] => utility
[patent_app_number] => 11/649451
[patent_app_country] => US
[patent_app_date] => 2007-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 24
[patent_no_of_words] => 8943
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/501/07501263.pdf
[firstpage_image] =>[orig_patent_app_number] => 11649451
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/649451 | Nucleic acids encoding mammalian T-type calcium channels | Jan 2, 2007 | Issued |
Array
(
[id] => 5260876
[patent_doc_number] => 20070214509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Methods and systems for identifying compounds that modulate alpha-synuclein aggregation'
[patent_app_type] => utility
[patent_app_number] => 11/644616
[patent_app_country] => US
[patent_app_date] => 2006-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4077
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20070214509.pdf
[firstpage_image] =>[orig_patent_app_number] => 11644616
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/644616 | Methods and systems for identifying compounds that modulate alpha-synuclein aggregation | Dec 21, 2006 | Abandoned |
Array
(
[id] => 5010557
[patent_doc_number] => 20070281036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'System and method of delivering a desired material to a cell'
[patent_app_type] => utility
[patent_app_number] => 11/641605
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 28466
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20070281036.pdf
[firstpage_image] =>[orig_patent_app_number] => 11641605
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/641605 | System and method of delivering a desired material to a cell | Dec 18, 2006 | Abandoned |